0
0
8/8/22 at 12:07pm
Organization
CNBC
Author
Samantha Subin
32 words
0
Comments
Goldman Sachs says it's time for investors to put their money in Rhythm Pharmaceuticals
You are the first to view
https://www.cnbc.com/2022/08/08/goldman-sachs-says-buy-this-biopharma-stock-thats-poised-to-rally-nearly-40percent-from-here.html
Create an account
or login to join the discussion